BriaCell Therapeutics Corp. (BCTX)
3.575
0.00 (0.00%)
USD |
NASDAQ |
Sep 08, 16:00
3.54
-0.04
(-0.98%)
After-Hours: 20:00
BriaCell Therapeutics Market Cap : 25.92M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 25.92M |
| September 04, 2026 | 25.88M |
| September 03, 2026 | 25.59M |
| September 02, 2026 | 25.88M |
| September 01, 2026 | 26.32M |
| August 31, 2026 | 26.03M |
| August 28, 2026 | 27.04M |
| August 27, 2026 | 26.90M |
| August 26, 2026 | 29.22M |
| August 25, 2026 | 27.33M |
| August 24, 2026 | 25.09M |
| August 21, 2026 | 29.51M |
| August 20, 2026 | 28.49M |
| August 19, 2026 | 28.71M |
| August 18, 2026 | 25.59M |
| August 17, 2026 | 24.58M |
| August 14, 2026 | 24.94M |
| August 13, 2026 | 24.94M |
| August 12, 2026 | 24.72M |
| August 11, 2026 | 25.01M |
| August 10, 2026 | 24.58M |
| August 07, 2026 | 26.39M |
| August 06, 2026 | 25.01M |
| August 05, 2026 | 25.38M |
| August 04, 2026 | 24.43M |
| Date | Value |
|---|---|
| August 03, 2026 | 24.36M |
| July 31, 2026 | 24.94M |
| July 30, 2026 | 26.32M |
| July 29, 2026 | 24.65M |
| July 28, 2026 | 25.16M |
| July 27, 2026 | 25.74M |
| July 24, 2026 | 25.96M |
| July 23, 2026 | 26.97M |
| July 22, 2026 | 26.10M |
| July 21, 2026 | 27.19M |
| July 20, 2026 | 26.43M |
| July 17, 2026 | 27.04M |
| July 16, 2026 | 27.91M |
| July 15, 2026 | 28.57M |
| July 14, 2026 | 26.83M |
| July 13, 2026 | 27.19M |
| July 10, 2026 | 28.57M |
| July 09, 2026 | 26.39M |
| July 08, 2026 | 26.83M |
| July 07, 2026 | 25.30M |
| July 06, 2026 | 25.38M |
| July 02, 2026 | 23.64M |
| July 01, 2026 | 25.16M |
| June 30, 2026 | 23.49M |
| June 29, 2026 | 22.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Edesa Biotech, Inc. | 45.56M |
| ProMIS Neurosciences, Inc. | 112.37M |
| Arrowhead Pharmaceuticals, Inc. | 12.01B |
| Oncolytics Biotech, Inc. | 100.33M |
| Sangamo Therapeutics, Inc. | 66.66M |
Market Cap Related Metrics
| Price to Book Value | 1.077 |
| Price | 3.575 |
| Earnings Yield | -341.6% |